In oncology, daily oral administration of ginseng or ginsenoside Rb1 in mice bearing colon C26 cancer cells results in reduced levels of TNF-α and IL-6 cytokines in serum, without modifications of tumor growth [26]. This evidence concerns the gene IL6 and cancer.